In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scrip Team

Latest From Scrip Team

Pipeline Watch: Eight Approvals And Five Phase III Trial Updates

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Executives On The Move: Changes At The Top At Ocuphire Pharma, YS Biopharma And More

Recent executive moves in the industry include new CEOs at Latigo Biotherapeutics and YS Biopharma Co, plus new directors at Cingulate.

Executive Changes Leadership

Pipeline Watch: 10 Approvals And 10 Phase III Trial Updates

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Executives On The Move: Grifols, TYK Medicines And Terns Pharmaceuticals Announce Changes

Recent C-suite moves in the industry include a new CEO for Grifols and changes at the top at Aligos Therapeutics and Cytophage Technologies.

Executive Changes Leadership

Pipeline Watch: Five Approvals And 12 Phase III Trial Updates

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Executives On The Move: 18 New CFOs As Five Companies Welcome New CEOs

Recent moves in the industry include new chief financial officers at 17 firms, while there are C-suite moves at Madrigal Pharmaceuticals, ACADIA Pharmaceuticals and BMS buy, Mirati Therapeutics.

Executive Changes Leadership
See All
UsernamePublicRestriction

Register